Rising Pharma Holding, Inc. recalls

9 recalls on record · latest: March 3, 2026

Official U.S. recall history for Rising Pharma Holding, Inc., compiled from official government records.

Get recall alerts

Free email alert whenever Rising Pharma Holding, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

Rising Pharma Holding, Inc. recalls Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuti…

March 3, 2026 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specifications: An out-of-specification result ob…

Rising Pharma Holding, Inc. recalls Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharm…

October 7, 2025 · Drug & medication recalls Moderate risk Product mix up: complaint received that sealed medication bottle contained Carb…

Duloxetine Delayed-Release Capsules recalled over manufacturing violations

March 5, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended in…

Duloxetine Delayed-Release Capsules USP 20 mg recalled over manufacturing violations

December 30, 2024 · Drug & medication recalls Moderate risk CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended in…

Duloxetine DR Capsules USP 60 mg recalled over manufacturing violations

December 30, 2024 · Drug & medication recalls Moderate risk CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended in…

Duloxetine Delayed-Release Capsules USP 30 mg recalled over manufacturing violations

December 30, 2024 · Drug & medication recalls Moderate risk CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended in…

Duloxetine Delayed-Release Capsules USP recalled over manufacturing violations

November 19, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended in…

Duloxetine Delayed-Release Capsules USP recalled over manufacturing violations

November 19, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended in…

Duloxetine DR Capsules USP 60 mg recalled over manufacturing violations

November 19, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended in…